Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index; 21 of the 42 sources its claims cite were checked for support.
Abstract
Cellular senescence, a stress-induced irreversible growth arrest often characterized by expression of p16(Ink4a) (encoded by the Ink4a/Arf locus, also known as Cdkn2a) and a distinctive secretory phenotype, prevents the proliferation of preneoplastic cells and has beneficial roles in tissue remodelling during embryogenesis and wound healing. Senescent cells accumulate in various tissues and organs over time, and have been speculated to have a role in ageing. To explore the physiological relevance and consequences of naturally occurring senescent cells, here we use a previously established transgene, INK-ATTAC, to induce apoptosis in p16(Ink4a)-expressing cells of wild-type mice by injection of AP20187 twice a week starting at one year of age. We show that compared to vehicle alone, AP20187 treatment extended median lifespan in both male and female mice of two distinct genetic backgrounds. The clearance of p16(Ink4a)-positive cells delayed tumorigenesis and attenuated age-related deterioration of several organs without apparent side effects, including kidney, heart and fat, where clearance preserved the functionality of glomeruli, cardio-protective KATP channels and adipocytes, respectively. Thus, p16(Ink4a)-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs, and their therapeutic removal may be an attractive approach to extend healthy lifespan.
Overview
CoChat Summary
TL;DR
Clearance of naturally occurring p16Ink4a-positive senescent cells in non-progeroid INK-ATTAC mice starting at 12 months of age extended median lifespan and delayed multiple age-related pathologies. The authors conclude that p16Ink4a-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs.
Key findings
- AP20187 treatment extended median lifespan in both sexes and two genetic backgrounds: mixed-background mice by 27% and C57BL/6 mice by 24% when sexes were combined; sex-specific median lifespan increases ranged from 17% to 35%. Maximum lifespan was significantly increased only for mixed AP-treated males and females combined (p = 0.0295), not for C57BL/6 mice or individual sexes.
- Clearance delayed tumorigenesis and increased tumor latency without changing the incidence or spectrum of macroscopically detectable tumors at autopsy; median lifespan extension among AP-treated mice dying without tumors ranged from 24% to 42%.
- Clearance attenuated age-related deterioration in fat, kidney, heart, and eye: it prevented fat mass loss and adipogenesis marker declines, reduced glomerulosclerosis and blood urea nitrogen increases, reduced cardiomyocyte hypertrophy and preserved cardiac stress tolerance, and delayed cataract formation. It also prevented age-dependent reductions in spontaneous activity and exploratory behavior.
- Clearance was partial and tissue selective: p16Ink4a-positive cells were reduced in most tissues examined but not colon or liver. In iWAT, AP-treated mice had 8-fold fewer GFP+ adipocyte progenitors; X-Gal crystal-containing cells were 0.2% vs 1.6% in iWAT and 0.3% vs 1.2% in kidney for AP-treated vs untreated mice, respectively.
Methods
- Two consecutive cohorts of INK-ATTAC transgenic mice were injected twice weekly with AP20187 or vehicle beginning at 12 months of age until moribund or death. The first cohort was on a mixed 129Sv × C57BL/6J × FVB background fed a 9% fat diet; the second was on a congenic C57BL/6J background fed a 5% fat diet. Dosing was 0.2 μg AP20187/g body weight between 12 and 18 months and 2.0 μg/g thereafter in the mixed cohort, and 2.0 μg/g from 12 months in the C57BL/6J cohort.
- Lifespan was analyzed with survival curves and log-rank tests; maximum lifespan was tested with two-sided Wang-Allison tests. Healthspan analyses at 18 months included qRT-PCR for senescence and inflammation markers, FACS, SAβ-Gal staining, TEM with X-ray elemental analysis, echocardiography, cardiac stress tests, metabolic and behavioral assays, and histology.
- The paper states that no power calculations were used; sample sizes were based on previously published experiments where differences were observed. Investigators were blinded to allocation during experiments and outcome assessment except for rare instances where blinding was not possible.
Limitations
- The authors state that clearance was partial and several key tissues were refractory, including liver and colon; they note that further optimization of senescent cell removal protocols is needed.
- The authors state that repetitive vehicle injection stress may have negatively impacted longevity of male C57BL/6 mice, and that maximum lifespan was not extended in C57BL/6 AP-treated animals.
- The authors state that their limited analyses do not exclude the possibility that other p16Ink4a-positive non-senescent cells engage ATTAC and die upon AP exposure; they also note that no power calculations were used.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 5 Not valid · 8 Not checked · 114 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Earlier we have shown that, in BubR1 progeroid mice, ATTAC ablates p16 Ink4a -positive senescent cells upon administration of AP20187 (AP), a dimerizer that activates FKBP-fused Casp8 4 .”
What the sources say
- Supportedcites [4] 4. Baker DJ, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011; 479:232-236. [PubMed: 22048312] source
In the main text (Fig. 3a–e), AP20187-treated BubR1H/H;INK-ATTAC mice show reduced senescence markers, which the authors interpret as clearance of senescent cells. The Methods ('Mouse strains and drug treatments') identifies AP20187 as the dimer-inducing drug, and the main text describes activation of the FKBP–Casp8 fusion protein by AP20187. (LLM, conf=0.94)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“ATTAC was also not induced in peripheral blood T lymphocytes that robustly engage endogenous p16 Ink4a with aging without concomitant expression of multiple senescence markers 2 , 13 (Extended Data Fig. 2h), further implying that transgene induction is quite selective for senescence.”
What the sources say
- Not checked — no full text of the sourcecites [2] 2. Sharpless NE, Sherr CJ. Forging a signature of in vivo senescence. Nat Rev Cancer. 2015; 15:397408. [PubMed: 26105537] source
- Partly supportedcites [13] 13. Liu Y, et al. Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging. Aging Cell. 2009; 8:439-448. [PubMed: 19485966] sourceExperimental — accuracy not yet measured
The section ‘Increased p16 INK4a expression is associated with chronological age’ reports that p16 INK4a expression in peripheral blood T lymphocytes increases with age (page unavailable). It does not address ATTAC induction or establish whether those cells express multiple senescence markers, so it supports only the aging-related p16 portion of the attributed claim. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“When AP was administered during wound closure, healing was delayed with similar kinetics as 4- or 18-month-old ATTAC mice without prior AP treatment, indicating that acute senescence mechanisms are preserved with aging and not influenced by constitutive clearance of senescent cells 3 .”
What the sources say
- Could not verifycites [3] 3. van Deursen JM. The role of senescent cells in ageing. Nature. 2014; 509:439-446. [PubMed: 24848057] sourceExperimental — accuracy not yet measured
The 'Senescence in ageing and age-related disease' section says AP20187 was used to eliminate senescent cells in INK-ATTAC mice. The 'Acute versus chronic senescence' section discusses senescence during wound closure, but neither section reports AP administration during wound closure, delayed healing, or a comparison with untreated 4- or 18-month-old mice. Pages were not provided in our copy. (LLM, conf=0.76)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Consistent with a beneficial role of senescent cells only for the duration of wound repair 6 - 8 , 18-month-old AP-treated ATTAC mice repaired cutaneous wounds when drug administration was suspended during healing (Extended Data Fig. 10ac).”
What the sources say
- Could not verifycites [6] 6. Jun JI, Lau LF. The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol. 2010; 12:676-685. [PubMed: 20526329] sourceExperimental — accuracy not yet measured
The Methods (Animals and cutaneous wound healing) describe 12-week-old Ccn1 mice, and the Results report wound healing in those mice. Our copy does not report 18-month-old ATTAC mice, AP treatment, or suspension of treatment during healing. In the citing sentence, this citation appears to support the preceding background point about senescent cells in wound repair; the ATTAC observation is presented as the citing authors’ own Extended Data result. (LLM, conf=0.78)
- Could not verifycites [7] 7. Krizhanovsky V, et al. Senescence of activated stellate cells limits liver fibrosis. Cell. 2008; 134:657-667. [PubMed: 18724938] sourceExperimental — accuracy not yet measured
The Animals and Results sections describe mice studied for liver fibrosis, not AP-treated ATTAC mice or cutaneous wound repair. The Discussion suggests that senescence may be relevant to other wound-healing responses, but our copy does not report the specific wound-healing observation; I searched for cutaneous wound repair and senescence. (LLM, conf=0.78)
- Partly supportedcites [8] 8. Demaria M, et al. An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA. Dev Cell. 2014; 31:722-733. [PubMed: 25499914] sourceExperimental — accuracy not yet measured
The Results section ('Elimination of Senescent Cells Delays Cutaneous Wound Healing'; page unavailable) reports that senescent cells facilitate cutaneous wound repair. The Experimental Procedures ('Mice'; page unavailable) describe p16-3MR mice treated with GCV, not 18-month-old ATTAC mice treated with AP. Our copy does not report wound repair after AP administration was suspended during healing. (LLM, conf=0.84)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Clearance had no impact on the spectrum or incidence of postmortem tumors, which is consistent with the hypothesis that senescent cells help create a tissue microenvironment that promotes tumor progression 1 .”
What the sources say
- Could not verifycites [1] 1. Campisi J. Aging, cellular senescence, and cancer. Annual review of physiology. 2013; 75:685-705. sourceExperimental — accuracy not yet measured
The Senescent Cells and Cancer section discusses how senescent cells can promote tumor growth, but it does not report whether clearing them changed the spectrum or incidence of postmortem tumors. The Immune Clearance section discusses clearance by immune cells, not postmortem tumor outcomes. Searches for postmortem tumors and tumor incidence after clearance found no passage addressing that result. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
83 more claims
Create a free account to see all 135 claims and every source verdict.
- Probably not a substantial claim. 24
- It may state two separate claims as one. 25
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The expression of p16Ink4a is essentially undetectable in young and healthy tissues, but p16Ink4a+ cells accumulate in many aged or diseased tissues.18,19,21,22,23,28”
From Identifying specific functional roles for senescence across cell types (2024) · doi:10.1016/j.cell.2024.09.021 · cites this paper as [28]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Ablating p16+ cells in these mice suppresses age-related disease, extending the health span of two independent strains of transgenic mice: INK-ATTAC and p16-3MR (see Supplemental Figure 1 for a description of the models) (8–10).”
From Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span (2021) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“AP20187, a molecule that induces apoptosis in p16INK4a-expressing cells8”
From Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment (2017) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“supporting the notion that senescent cells progressively accumulate in the organism during aging at previously described rates for mice30.”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Glomerular endothelial cells140 and proximal tubular epithelial cells (TECs)140,141 become senescent with ageing in mice, showing increased SA-β-gal staining and Cdkn2a expression.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [141]
Experimental — accuracy not yet measured
77 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Statistical analysis
“For consistency in these comparisons, the following denotes significance in all figures: * P < 0.05, ** P < 0.01 and *** P < 0.001.”
§ Extended Data
“Log-rank tests were used to determine statistical significance. *, P<0.01; ** P<0.001; ***, P<0.001.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Mouse strains and drug treatments
“Mice from this cohort were randomly assigned to be injected with AP20187 (B/B homodimerizer, Clontech, Mountain View, CA, USA) or vehicle twice a week beginning at 12 months of age.”
§ Mouse strains and drug treatments
“Dosing was 0.2 μg AP20817/g body weight between 12 and 18 months (the same dose as previously used for senescent cell clearance in BubR1 progeroid mice; see reference 4), and 2.0 μg AP20187/g body weight from thereon.”
Citations
Cites
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 8×
“ATTAC MEFs were generated as previously described 4 .”
InfluentialSelf-citationAging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623 · cited 2×
“All studies described using ATTAC mice were performed on transgenic line 3, which contains 13 copies of the transgene inserted into a single locus (data available upon request).”
Cellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363 · cited 1×
“…p16 Ink4a -positive cells is not associated with any overt detrimental effects raise the possibility that this approach may be useful to treat aspects of age-related functional decline, age-related diseases that involve senescent cells, or side-effects of therapies that create senescent cells 36 .”
Self-citationAn Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Physiology of Local Renin-Angiotensin Systems
Paul, M., Poyan Mehr, A., & Kreutz, R. (2006) · Physiological Reviews · doi:10.1152/physrev.00036.2005 · Cited by 1,739 · cited 1×
“Angiotensin receptor blockers attenuate age-related glomerulosclerosis under normotensive conditions, which has led to the idea that overactivation of the local renin-angiotensin-aldosterone system (RAAS) drives the formation of sclerotic glomeruli 31, 32 .”
Programmed cell senescence during mammalian embryonic development
Muñoz-Espín, D., Cañamero, M., Maraver, A., Gómez-López, G., Contreras, J., Murillo-Cuesta, S., Rodríguez-Baeza, A., Varela-Nieto, I., Ruberte, J., Collado, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.019 · Cited by 1,428
Senescence is a developmental mechanism that contributes to embryonic growth and patterning
Storer, M., Mas, A., Robert-Moreno, A., Pecoraro, M., Ortells, M. C., Di Giacomo, V., Yosef, R., Pilpel, N., Krizhanovsky, V., Sharpe, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.041 · Cited by 1,186 · cited 1×
“Furthermore, recent studies showing that senescent cells have beneficial effects in injury repair and tissue remodelling 6–10 have called into question the simplistic view of senescence as only a driver of age-dependent pathologies, raising the specter that senescent cell clearance might remove…”
Forging a signature of in vivo senescence
Sharpless, N. E., & Sherr, C. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3960 · Cited by 1,104 · cited 1×
“ATTAC was also not induced in peripheral blood T lymphocytes that robustly engage endogenous p16 Ink4a with aging without concomitant expression of multiple senescence markers 2, 13 (Extended Data Fig.”
Research works printed but not linked: 2
- 38. Baker DJ, et al. Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan. Nat Cell Biol. 2012; 15:96-102. [PubMed: 23242215] · DOI · Paper page
- 48. Baker DJ, et al. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nature genetics. 2004; 36:744-749. [PubMed: 15208629] · DOI · Paper page
Cited by
Items 1,901–2,000 of 2,883
Pursuing healthy aging and longevity through natural product and stem cell-driven rejuvenation
Wu, D., Xu, Q., Wu, S., Tan, J., Khan, F. A., Pandupuspitasari, N. S., & Huang, C. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117359 · Cited by 11
Modelling ageing and age-related disease
Bellantuono, I., & Potter, P. K. (2016) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2017.07.005 · Cited by 9
Dai, C., Jia, J., Kot, A., Liu, X., Liu, L., Jiang, M., Lane, N. E., Wise, B. L., & Yao, W. (2019) · Bone · doi:10.1016/j.bone.2019.115196 · Cited by 8
Burnaevskiy, N., Oshima, J., & Mendenhall, A. (2022) · GeroScience · doi:10.1007/s11357-022-00709-x · Cited by 11
Clinical Impact and Mechanisms of Nonatherosclerotic Vascular Aging: The New Kid to Be Blocked
Jouabadi, S. M., Ataabadi, E. A., Golshiri, K., Bos, D., Stricker, B. H. C., Danser, A. H. J., Mattace-Raso, F. U. S., & Roks, A. J. M. (2023) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2023.07.022 · Cited by 11
An expedited screening platform for the discovery of anti-ageing compounds in vitro and in vivo
Lujan, C., Tyler, E. J., Ecker, S., Webster, A. P., Stead, E. R., Martinez-Miguel, V. E., Milligan, D., Garbe, J. C., Stampfer, M. R., Beck, S., et al. (2024) · Genome Medicine · doi:10.1186/s13073-024-01349-w · Cited by 9
Tilman, G., Dupré, E., Watteyne, L., Baert, C. A., Nolf, D., Benhaddi, F., Lambert, F., Daumerie, A., Bouzin, C., Lucas, S., et al. (2023) · Lupus Science & Medicine · doi:10.1136/lupus-2023-001010 · Cited by 11
Walters, H., & Cox, L. S. (2019) · Biogerontology · doi:10.1007/s10522-018-09792-0 · Cited by 7
Zhao, P., Chang, J., Chen, Y.-J., Sun, X., Ma, X., Zhou, C., Zhou, L., Wang, Y., & Yang, Y. (2024) · Phenomics · doi:10.1007/s43657-023-00132-y · Cited by 9
“As cellular senescence, damaged proteins accumulate to form aggregates, which further exacerbated the cellular senescence, while peroxisomes slows down the aging by counteracting this damage mechanism (Baker et al. 2016).”
Implications of cellular senescence in paediatric pituitary tumours
González-Meljem, J. M., & Martínez-Barberá, J. P. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104905 · Cited by 9
“37,38 Importantly, small molecule-guided elimination of senescent cells propelled further research implicating them in the development and/or progression of multiple pathologies including diabetes, atherosclerosis, rheumatoid arthritis, metabolic dysfunction, fi brosis (including in lungs, heart,…”
Length-independent telomere damage drives cardiomyocyte senescence
(2018) · doi:10.1101/394809 · Cited by 532
Sénescence et cancer: Double jeu
Goy, E., & Abbadie, C. (2018) · médecine/sciences · doi:10.1051/medsci/20183403010 · Cited by 10
Lee, J., Han, M., Wang, K., Butler, L. R., & Sinclair, D. A. (2026) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2026.101442 · Cited by 9
A Dual Role of the Senescence Marker P16Ink4a in Liver Endothelial Cell Function
Wagner, K., Safwan‐Zaiter, H., & Wagner, N. (2024) · Cells · doi:10.3390/cells13231929 · Cited by 10
“As P16Ink4a is commonly considered as a marker for senescence [17,32–38], we performed SA-β -galactosidase staining of Cd31+ and Cd146+ cell populations transduced with either p16 small hairpin or overexpression constructs and the respective controls.”
Functional similarities of microRNAs across different types of tissue stem cells in aging
Watanabe, K., Ikuno, Y., Kakeya, Y., Kito, H., Matsubara, A., Kaneda, M., Katsuyama, Y., & Naka-Kaneda, H. (2018) · Inflammation and Regeneration · doi:10.1186/s41232-018-0066-9 · Cited by 9
The original colorimetric method to detect cellular senescence
Dimri, M., & Dimri, G. P. (2022) · Methods in cell biology · doi:10.1016/bs.mcb.2022.09.005 · Cited by 10
Li, X., Ma, B., Liao, M., Li, L., Zhang, X., Du, M., Yu, J., He, S., & Yan, H. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2707207 · Cited by 8
Nong, C., Wu, Z., Yang, C., Xü, W., Luo, L., Zhou, J., Shen, L., Chen, Y., Yuan, Y., & Hu, G. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1449423 · Cited by 8
Yang, G., Schmid-Siegel, M., Heissenberger, C., Kos‐Braun, I. C., Prechtl, M., Meca-Laguna, G., Rocha, M., Wagner-Schrittwieser, A., Pils, V., Meixner, B., et al. (2024) · Journal of Cell Science · doi:10.1242/jcs.261930 · Cited by 9
Neri, F., Zheng, S., Watson, M. A., Desprez, P. Y., Gerencser, A. A., Campisi, J., Wirtz, D., Wu, P.-H., & Schilling, B. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.22.600200 · Cited by 7
Breed-related expression patterns of Ki67, γH2AX, and p21 during ageing in the canine liver
Hardwick, L. J. A., Kortum, A. J., Constantino‐Casas, F., & Watson, P. (2020) · Veterinary Research Communications · doi:10.1007/s11259-020-09784-x · Cited by 11
Nutrition Interventions of Herbal Compounds on Cellular Senescence
Chen, Z., Wu, Y., Lin, Q., Cai, J., Liu, X., & Liang, Y. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1059257 · Cited by 9
Skeletal muscle cell aging and stem cells
Rafi, S. T. M., Sambandam, Y., Sittadjody, S., Pathak, S., Ramachandran, I., & Kumaran, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820071-1.00009-8 · Cited by 11
Elimination of senescent cells prevents neurodegeneration in mice
Penney, J., & Tsai, L. (2018) · Nature · doi:10.1038/d41586-018-06677-7 · Cited by 7
Ji, N., Wu, C.-G., Wang, X.-D., Song, Z.-X., Wu, P., Liu, X., Feng, X., Wang, X., Wang, X., & Lv, Z. (2023) · Current Medical Science · doi:10.1007/s11596-022-2688-z · Cited by 7
Wang, S., Li, B., Cai, Z., Hugo, C., Li, J., Sun, Y. E., Lü, Q., Remaley, A. T., Julia, T. C. W., Chui, H. C., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4373201/v1 · Cited by 7
“However, the precise drivers of cellular senescence in the brain and their relationship with neuropathological markers of AD remain poorly understood.”
Tian, M., Ma, J., Li, Z., Ye, C., Cui, X., Wang, G., Liu, S., Qudus, M. S., Afaq, U., Fan, H. M., et al. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02466-8 · Cited by 8
“The accumulation of senescent cells is a key factor in aging [20, 21].”
Recent progress in stem cell and immune cell-based interventions for aging and age-related disorders
Li, H., Han, D., Zong, F., Zhang, Y., Han, Z., & Xu, Z. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1638168 · Cited by 8
Papismadov, N., & Krizhanovsky, V. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-00749-6 · Cited by 7
Comprehensive investigations of key mitochondrial metabolic changes in senescent human fibroblasts
Ghneim, H. K., Alfhili, M. A., Al-Harbi, S. O. E., Alhusayni, S. M., Abudawood, M., Aljaser, F., & Al‐Sheikh, Y. A. (2022) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2022.26.4.263 · Cited by 7
Cellular senescence in age-related musculoskeletal diseases
Xiong, J., Guo, Q., & Luo, X. (2025) · Frontiers of Medicine · doi:10.1007/s11684-025-1125-7 · Cited by 10
Contribution of Retrotransposable Elements to Aging
Kreiling, J. A., Jones, B. C., Wood, J. G., Cecco, M. D., Criscione, S. W., Neretti, N., Helfand, S. L., & Sedivy, J. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-48344-3_13 · Cited by 7
Powering senescence: The ugly side of mitochondria
Correia‐Melo, C., Birch, J., & Passos, J. F. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1204852 · Cited by 8
Maintenance and repair of an aging life cycle
Baar, M. P., van Willigenburg, H., & de Keizer, P. L. J. (2017) · Oncotarget · doi:10.18632/oncotarget.18046 · Cited by 7
Targeting the stress support network regulated by autophagy and senescence for cancer treatment
Kim, J., Lee, Y., Roh, K., Kim, M.-S., & Kang, C. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.01.003 · Cited by 7
ML216 Prevents DNA Damage-Induced Senescence by Modulating DBC1–BLM Interaction
Cui, F., Han, X., Zhang, X., Wang, S., Liang, N., Tan, Q., Sha, W., & Li, J. (2022) · Cells · doi:10.3390/cells12010145 · Cited by 8
Kitaeva, K. V., Solovyeva, V. V., Blatt, N. L., & Rizvanov, A. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25010643 · Cited by 7
“It is known that deletion of p16-positive senescent cells delays the onset and progression of age-related pathologies in mice in vivo and prolongs the lifespan of prematurely and naturally aging mice [32,33].”
BackgroundTachikart, Y., Malaise, O., Constantinides, M., Jørgensen, C., & Brondello, J. (2018) · médecine/sciences · doi:10.1051/medsci/20183406014 · Cited by 9
Sharma, R., & Diwan, B. (2022) · Human Nutrition & Metabolism · doi:10.1016/j.hnm.2022.200149 · Cited by 11
Targeting senescence and inflammation in chronic destructive TNF-driven joint pathology
Vlachogiannis, N. I., Evangelou, K., Ntari, L., Nikolaou, C., Denis, M. C., Karagianni, N., Veroutis, D., Gorgoulis, V. G., Kollias, G. A., & Sfikakis, P. P. (2023) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2023.111856 · Cited by 9
Targeted Senolytic Strategies Based on the Senescent Surfaceome
Ekpenyong‐Akiba, A. E., Poblocka, M., & Macip, S. (2020) · Healthy ageing and longevity · doi:10.1007/978-3-030-44903-2_6 · Cited by 9
Senotherapeutic peptide reduces skin biological age and improves skin health markersPreprint
Zonari, A. A. C., Brace, L. E., Al-Katib, K., Porto, W. F., Foyt, D. A., Guiang, M., Cruz, E. A. O., Marshall, B., Salgueiro, W. G., Inan, M. D., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.30.362822 · Cited by 7
Yousef, A., Fang, L., Heidari, M., Kranrod, J. W., & Seubert, J. M. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1486717 · Cited by 10
Loss of fragile WWOX gene leads to senescence escape and genome instability
Cheng, H., Huang, P.-H., Lai, F., Jan, M., Chen, Y., Chen, S.-Y., Chen, W., Hsu, C., Huang, W., & Hsu, L. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04950-1 · Cited by 8
Senolytics under scrutiny in the quest to slow aging
de Magalhães, J. P. (2025) · Nature Biotechnology · doi:10.1038/s41587-025-02740-7 · Cited by 9
Du, Q., Jovanović, S., Sukhodub, A., Ngoi, Y. S., Lal, A., Zheleva, M., & Jovanović, A. (2018) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2018.08.005 · Cited by 7
Ageing as a druggable process: Moving forward
Prattichizzo, F. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.01.025 · Cited by 6
The Role of Metallodrugs in Cellular Senescence
Redrado, M., & Fernández‐Moreira, V. (2023) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.202200593 · Cited by 6
IMMP2L: a mitochondrial protease suppressing cellular senescence
Sica, V., & Kroemer, G. (2018) · Cell Research · doi:10.1038/s41422-018-0051-5 · Cited by 8
Senotherapy for attenuation of cellular senescence in aging and organ implantation
Kang, D. H., Park, Y. S., & Lee, D. Y. (2017) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2017.08.053 · Cited by 6
Gadecka, A., Koblowska, M., Kossowska, H., Iwanicka‐Nowicka, R., Janiszewska, D., Mosieniak, G., Bojakowski, K., Goryca, K., & Bielak-Żmijewska, A. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02315-8 · Cited by 7
“Elimination of senescent cells from tissues and organs has proven to be a promising rejuvenating mechanism [1–2].”
He, Y., Zheng, G., & Zhou, D. (2020) · Healthy ageing and longevity · doi:10.1007/978-3-030-44903-2_1 · Cited by 7
Zhang, X.-X., Yu, X., Zhu, L., & Luo, J.-H. (2023) · Medicine · doi:10.1097/md.0000000000035923 · Cited by 6
Senescence Can Be BETter without the SASP?
Vizioli, M. G., & Adams, P. D. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0485 · Cited by 6
Evidence for a non-stochastic two-field hypothesis for persistent skin cancer risk
Konger, R. L., Ren, L., Sahu, R. P., Derr-Yellin, E. C., & Kim, Y. L. (2020) · Scientific Reports · doi:10.1038/s41598-020-75864-2 · Cited by 6
Science‐in‐brief: The importance of senescence in tendinopathy: New opportunities
Kelly, E. F., Smith, R. K. W., Dudhia, J., & Faragher, R. (2020) · Equine Veterinary Journal · doi:10.1111/evj.13228 · Cited by 6
Jung, S., & Ahn, B. Y. (2024) · Nutrients · doi:10.3390/nu16183177 · Cited by 9
“…and promote the secretion of pro-inflammatory cytokines, chemokines, and matrix metalloproteinases, collectively known as the senescence-associated secretory phenotype (SASP), which impede the optimal functioning of the immune system, thereby precipitating a state of systemic inflammation [11,12].”
BackgroundMethodWu, E., Li, X., Ni, Z., Zhao, F., & Jia, C. (2026) · Journal of Oral Microbiology · doi:10.1080/20002297.2026.2616138 · Cited by 9
The senescent heart and atrial fibrillation
Pandey, A. C., Bidaoui, G., Younes, H., Tsakiris, E., & Marrouche, N. F. (2025) · Heart Rhythm · doi:10.1016/j.hrthm.2025.06.005 · Cited by 7
Ghanam, A. R., Ke, S., Wang, S., Elgendy, R., Xie, C., Wang, S., Zhang, R., Wei, M., Liu, W., Cao, J., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105740 · Cited by 7
“On the other hand, clearance of senescent cells in the body improves late-life health and delays age-associated frailty in mice.(49,50)”
BackgroundSenolytics prevent age-associated changes in female mice brain
Faria, O. W., Soares, M. S. P., de Mello, J. E., Alvez, F. L., Luduvico, K. P., Garcia, D. N., Schneider, A., Masternak, M. M., Spanevello, R. M., & Stefanello, F. M. (2024) · Neuroscience Letters · doi:10.1016/j.neulet.2024.137730 · Cited by 6
CD38 ‐Targeting Peptide Vaccine Ameliorates Aging‐Associated Phenotypes in Mice
Yu, S., Zhi-qiang, L., Tang, Y., Chen, Y., Ma, Y., Du, K., Zong, Z., Feng, K., Wei, Y., Chen, L., et al. (2025) · Aging Cell · doi:10.1111/acel.70147 · Cited by 8
Henze, L., Walter, U., Escobar, H. M., Junghanß, C., Jaster, R., Köhling, R., Lange, F., Salehzadeh‐Yazdi, A., Wolkenhauer, O., Hamed, M., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-039560 · Cited by 7
Network Topology of Biological Aging and Geroscience-Guided Approaches to COVID-19
LANDAY, A. L., Bartley, J. M., Banerjee, D., Hargis, G. R., Haynes, L., Keshavarzian, A., Kuo, C., Kwon, O. S., Li, S., Li, S., et al. (2021) · Frontiers in Aging · doi:10.3389/fragi.2021.695218 · Cited by 7
Acetyltransferase in cardiovascular disease and aging
Keller, M. A., & Nakamura, M. (2024) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2024.21 · Cited by 9
Mitochondrial function maintenance and mitochondrial training in ageing and related diseases
Gao, G., Xie, Z., & Huang, H. (2025) · Journal of Holistic Integrative Pharmacy · doi:10.1016/j.jhip.2025.04.001 · Cited by 7
Ma, S., Xia, T., Wang, X., & Wang, H. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1139789 · Cited by 6
“, 2020), a suite of pro-inflammatory cytokines which could not only improve tissue homeostasis through promoting myofibroblast differentiation as well as wound healing in young people (Baker et al., 2016), they generate a proinflammatory environment and recruit immune cells to accelerate degenerative changes (Muñoz-Es…”
BackgroundMitochondria-Targeted Catalase Does Not Suppress Development of Cellular Senescence during Aging
Mogck, B. A., Jezak, S. T., & Wiley, C. D. (2024) · Biomedicines · doi:10.3390/biomedicines12020414 · Cited by 7
“Senescent cells accumulate during aging, and eliminating them extends both life span and health span [18,22].”
BackgroundRedefining cell death: ferroptosis as a game-changer in ophthalmology
Wei, Y., Lin, Y., Li, Y., Liu, J., Yang, Y., Chen, H., Han, Z., Wang, K., Tao, Q., Ju, Y., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1709354 · Cited by 10
“One study showed that immune cells, mainly NK cells, eliminate senescent cells and increase animal lifespan by 20% – 30% (197).”
Kim, H., Noh, M., Zhang, H., Kim, Y., Park, S., Park, J., & Kwon, Y. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00410-x · Cited by 7
Stress‐induced and ATF7‐dependent epigenetic change influences cellular senescence
Maekawa, T., Liu, B., Liu, Y., Yoshida, K., Muratani, M., Chatton, B., & Ishii, S. (2019) · Genes to Cells · doi:10.1111/gtc.12713 · Cited by 6
A Senescent Cluster in Aged Human Hematopoietic Stem Cell Compartment as Target for Senotherapy
Poisa-Beiro, L., Landry, J. J. M., Yan, B., Kardorff, M., Eckstein, V., Villacorta, L., Krammer, P. H., Zaugg, J. B., Gavin, A., Beneš, V., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020787 · Cited by 7
Watson, M. A., Devrukhkar, P. R., Murad, N., Wu, F., Kim, M. J., Anvari, H., Tran, U., Martin, N. G., Tran, T., Zaza, G., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.03.692228 · Cited by 7
Oral Senescence: From Molecular Biology to Clinical Research
Parkinson, E. K., & Prime, S. S. (2022) · Frontiers in Dental Medicine · doi:10.3389/fdmed.2022.822397 · Cited by 7
Cellular senescence as a therapeutic target for aging intervention
Bi, Y., & Ji, G. (2026) · Biomedical Journal · doi:10.1016/j.bj.2026.100948 · Cited by 11
“In naturally aged mice, intermittent elimination of p16 Ink4a + cells beginning in midlife extends median lifespan and delays multiple age-associated pathologies, consistent with a systemic contribution of SnCs burden to functional decline [36,46].”
Ito, T. K., Yamamoto, N., Nakajima, S., & Schaffer, S. W. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-94-024-1079-2_39 · Cited by 7
Recent Advances in Senotherapeutics Delivery
Choi, J. Y., Yee, S. F., Tchangalova, T., Yang, G., & Fisher, J. P. (2022) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2021.0212 · Cited by 6
Chen, L., Lin, A., Luo, P., & Miao, K. (2025) · Nano Research · doi:10.26599/nr.2025.94907609 · Cited by 6
Loss of SATB1 Induces a p21 Dependent Cellular Senescence Phenotype in Dopaminergic Neurons
(2018) · doi:10.1101/452243 · Cited by 180
Zhao, F., Han, H., Wang, J., Wang, J., Zhai, J., & Zhu, G. (2025) · Cells · doi:10.3390/cells14040249 · Cited by 7
“Notably, even a small proportion of senescent cells, ranging from 10% to 15% of the total cell volume, is adequate to cause tissue dysfunction in aged primates [56,57].”
Sentinel p16 INK4a + cells in the basement membrane form a reparative niche in the lungPreprint
de Mochel, N. R., Cheong, K. N., Cassandras, M., Wang, C., Krasilnikov, M., Matatia, P. R., Molofsky, A. B., Campisi, J., & Peng, T. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.10.142893 · Cited by 6
(2023) · doi:10.1101/2023.08.30.555644 · Cited by 82
Carvalho, D. B., Díaz‐Amarilla, P., Dapueto, R., Santi, M. D., Duarte, P., Savio, E., Engler, H., Abin‐Carriquiry, J. A., & Arredondo, F. (2023) · Journal of Molecular Neuroscience · doi:10.1007/s12031-023-02105-2 · Cited by 8
“Cellular senescence is a key feature of aging that contributes to tissue dysfunction (Baker et al. 2016; Kritsilis et al. 2018).”
BackgroundSemeraro, M. D., Beltrami, A. P., Kharrat, F., Almer, G., Sedej, S., Renner, W., Gruber, H., Curcio, F., & Herrmann, M. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1080077 · Cited by 8
“In vivo experiments have shown that the removal of senescent cells prolongs the median life span of mice (17).”
BackgroundWu, T., Jiang, D., Zou, M., Sun, W., Wu, D., Cui, J., Huntress, I., Peng, X., & Li, G. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab890 · Cited by 6
Polyunsaturated lipid senolytics exploit a ferroptotic vulnerability in senescent cells
Zhang, L. J., Salekeen, R., Soto-Palma, C., Elsallabi, O., Ye, H., Hughes, B., Zhang, B., Nunes, A., Lee, K.-A., Xu, W., et al. (2026) · Cell Press Blue · doi:10.1016/j.cpblue.2026.100004 · Cited by 15
An antioxidant suppressed lung cellular senescence and enhanced pulmonary function in aged mice
Kawaguchi, K., Hashimoto, M., & Sugimoto, M. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.12.112 · Cited by 7
The “Naked Truth”: Naked Mole-Rats Do Get Cancer
Piersigilli, A., & Meyerholz, D. K. (2016) · Veterinary Pathology · doi:10.1177/0300985816638431 · Cited by 8
Targeting senescent cell clearance: An approach to delay aging and age-associated disorders
Qiu, Z., Jia, J., Zou, H., Ao, Y., Liu, B., & Wang, Z. (2021) · Translational Medicine of Aging · doi:10.1016/j.tma.2020.12.001 · Cited by 7
Neri, F., Zheng, S., Watson, M. A., Desprez, P.-Y., Gerencser, A. A., Campisi, J., Wirtz, D., Wu, P.-H., & Schilling, B. (2025) · Aging · doi:10.18632/aging.206299 · Cited by 6
Rejuvenation of the Aging Heart: Molecular Determinants and Applications
Alibhai, F. J., & Li, R. (2024) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2024.03.004 · Cited by 9
A Multidimensional Systems Biology Analysis of Cellular Senescence in Ageing and DiseasePreprint
Avelar, R. A., Ortega, J. G., Tăcutu, R., Tyler, E. J., Bennett, D. F., Binetti, P., Budovsky, A., Chatsirisupachai, K., Johnson, E., Murray, A., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/743781 · Cited by 6
Xu, Y., Liu, S., Zhou, Z., Qin, H., Zhang, Y., Zhang, G., Ma, H., Han, X., Liu, H., & Liu, Z. (2025) · Human Molecular Genetics · doi:10.1093/hmg/ddae189 · Cited by 6
Greenberg, E. F., & Vatolin, S. (2018) · Rejuvenation Research · doi:10.1089/rej.2017.1973 · Cited by 7
Targeting the microbiota-mitochondria crosstalk in neurodegeneration with senotherapeutics
Homolak, J. (2023) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2023.02.018 · Cited by 10
Advances in pharmacological interventions of aging in mice
Qian, M., & Liu, B. (2019) · Translational Medicine of Aging · doi:10.1016/j.tma.2019.11.002 · Cited by 6
Kim, K., Admasu, T. D., Stolzing, A., & Sharma, A. (2022) · Aging · doi:10.18632/aging.203931 · Cited by 9
p16-dependent upregulation of PD-L1 impairs immunosurveillance of senescent cellsPreprint
Majewska, J., Agrawal, A., Mayo, A., Roitman, L., Chatterjee, R., Kralova, J. S., Landsberger, T., Katzenelenbogen, Y., Meir-Salame, T., Hagai, E., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.30.524522 · Cited by 5
“2 software as described previously (3).”
BackgroundHyperglutaminolysis drives senescence and aging through arginine-mTORC1 axis activation
Chen, H., Huang, N., Xu, W., Yang, Y., Wang, F., Gong, H., Zhou, J., Tai, H., Zhao, T., Zhang, J., et al. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02576-w · Cited by 8
“1,2,4,5 11 However, many gaps remain on our way to make clear the mechanism underlying the aging-related metabolic dysregulation, which largely hinder the geriatric research and the development of human health.”
Metadata
- Authors
- Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., Khazaie, K., Miller, J. D., & van Deursen, J. M.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Baker, Darren J.
- van Deursen, Jan M.
- ORCID
- Venue
- Nature
- Published
- 2016-02
- Volume
- 530
- Issue
- 7589
- Pages
- 184-189
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4845101
- OpenAlex
- W2266290735
- Cited by
- 2,876
- References
- 50
- Citations by year
- 2026: 254 · 2025: 253 · 2024: 318 · 2023: 298 · 2022: 305 · 2021: 286 · 2020: 312 · 2019: 279 · 2018: 236 · 2017: 210 · 2016: 123
- FWCI
- 116.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institute on Aging (P01AG041122, R37AG013925)
- National Heart, Lung, and Blood Institute (R01HL111121)
- National Cancer Institute (R01CA166347, R01CA096985, P30CA015083)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- cellular senescence, p16INK4a, senolytics, healthspan, aging, senescent cell clearance, carcinogenesis, renal function, cardiac KATP channels, adipocytes, AP20187, CDKN2A
- MeSH terms
- Aging, Animals, Cell Separation, Cell Transformation, Neoplastic, Epithelial Cells, Female, Health, Kidney, Lipodystrophy, Longevity, Male, Myocardium, Organ Specificity, Stem Cells, Time Factors, Cellular Senescence, Apoptosis, Adipocytes, Cyclin-Dependent Kinase Inhibitor p16, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.